Emergent Biosolutions (ER4) Q2 2026 Earnings Report
CH:ER4 Q2 2026 EPS Results
- Actual EPS
- CHF 0.49
- Consensus EPS
- -CHF 0.07
- Beat/Miss
- Beat by +CHF 0.56
- One Year Ago EPS
- CHF 0.13
CH:ER4 Q2 2026 Revenue Results
- Actual Revenue
- CHF 192.06M
- Expected Revenue
- CHF 145.50M
- Beat/Miss
- Beat by +CHF 46.56M
- YoY Revenue Growth
- +66.29%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- After Close
- Conference Call
- Wednesday, August 5, 2026
CH:ER4 Upcoming Earnings
Emergent Biosolutions's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:ER4 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ER4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.06- | -0.35 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.32-0.30 | 0.87 | -133.96% (-1.16) | |
| Aug 05, 2026 | 2026 (Q2) | -0.070.49 | 0.13 | 275.00% (+0.36) | |
| Apr 30, 2026 | 2026 (Q1) | -0.200.17 | 0.58 | -70.42% (-0.41) | |
| Feb 26, 2026 | 2025 (Q4) | 0.09-0.35 | 0.04 | -960.00% (-0.39) | |
| Oct 29, 2025 | 2025 (Q3) | -0.100.87 | 1.12 | -22.63% (-0.25) | |
| Aug 06, 2025 | 2025 (Q2) | -0.400.13 | -1.9 | 106.90% (+2.03) | |
| May 07, 2025 | 2025 (Q1) | 0.360.58 | 0.48 | 20.34% (+0.10) | |
| Mar 03, 2025 | 2024 (Q4) | -0.410.04 | -0.63 | 106.49% (+0.67) | |
| Nov 06, 2024 | 2024 (Q3) | 0.081.12 | -0.44 | 353.70% (+1.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
